These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3274458)

  • 21. The effect of cyclosporine A in cadaver donor retransplants: a surprising effect of the sex of the donor.
    Cecka JM; Cicciarelli J; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1842-4. PubMed ID: 3274440
    [No Abstract]   [Full Text] [Related]  

  • 22. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
    Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
    [No Abstract]   [Full Text] [Related]  

  • 23. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
    Alexander JW; Vaughn WK; Pfaff WW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcome of kidney transplantation in highly sensitized patients in Scandiatransplant.
    Lamm LU; Madsen M; Fjeldborg D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):729-30. PubMed ID: 3274855
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal replacement therapy in the cyclosporine era: results of a national transplantation program.
    Albrechtsen D; Berg KJ; Brekke I; Fauchald P; Jakobsen A; Sødal G; Talseth T; Leivestad T; Flatmark A
    Transplant Proc; 1990 Feb; 22(1):155-6. PubMed ID: 2309295
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of autolymphocytoxic antibody in the highly presensitized patient.
    Ettenger R; Robertson L
    Transplant Proc; 1987 Feb; 19(1 Pt 1):775-6. PubMed ID: 3274871
    [No Abstract]   [Full Text] [Related]  

  • 29. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients.
    Rocher LL; Landis C; Dafoe DC; Keyserling C; Swartz RD; Campbell DA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2093-5. PubMed ID: 3274476
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclosporine: its time of impact on kidney graft survival.
    Gilks WR; Bradley BA; Gore SM
    Transplant Proc; 1990 Oct; 22(5):2282. PubMed ID: 2219368
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of the effects of cyclosporine and HLA-typed source leukocyte transfusions (apheresis by-products) on the immune systems of highly sensitized prospective renal allograft recipients.
    Weir MR; Shen SY; Dagher FJ; Bentley FR; Lesko L; Sadler JH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):735-7. PubMed ID: 3547838
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of immunosuppression in long surviving (LS) monkey allograft recipients.
    Thomas J; Carver M; Cunningham P; Saldanha C; Thomas F
    Transplant Proc; 1989 Feb; 21(1 Pt 1):388-90. PubMed ID: 2650156
    [No Abstract]   [Full Text] [Related]  

  • 34. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
    Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
    Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipients.
    Metselaar HJ; Jeekel J; Rothbarth PH; Vaessen LM; Wenting GJ; Weimar W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2181-2. PubMed ID: 3274486
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of HLA typing and transfusions on cyclosporine-treated renal-allograft recipients.
    Cats S; Terasaki P; Perdue S; Mickey MR
    N Engl J Med; 1984 Sep; 311(10):675-6. PubMed ID: 6382003
    [No Abstract]   [Full Text] [Related]  

  • 38. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
    Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.